These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1099016)

  • 1. Acid mucopolysaccharide metabolism in leprosy. 3. Hyaluronic acid mycobacterial growth enhancement, and growth suppression by saccharic acid and vitamin C as inhibitors of beta-glucuronidase.
    Matsuo E; Skinsnes OK; Chang PH
    Int J Lepr Other Mycobact Dis; 1975; 43(1):1-13. PubMed ID: 1099016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid mucopolysaccharide metabolism in leprosy. 2. Subcellular localization of hyaluronic acid and beta-glucuronidase in leprous infiltrates suggestive of a host-Mycobacterium leprae metabolic relationship.
    Matsuo E; Skinsnes OK
    Int J Lepr Other Mycobact Dis; 1974; 42(4):399-411. PubMed ID: 4282081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad.
    Hastings RC; Richard V; Christy SA; Morales MJ
    Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural features of the multiplication of human and murine leprosy bacilli in macrophages of nude mice.
    Fukunishi Y; Okada S; Nishiura M; Kohsaka K
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):68-75. PubMed ID: 7042613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Histochemical analysis of leprous tissue leads to cultivation of leprosy bacilli.
    Skinsnes OK
    Arch Pathol Lab Med; 1976 Apr; 100(4):173-4. PubMed ID: 786212
    [No Abstract]   [Full Text] [Related]  

  • 6. Acid mucopolysaccharide metabolism in leprosy. 1. Storage of hyaluronic acid and its possible significance in the pathogenesis of leprosy.
    Skinsnes OK; Matsuo E
    Int J Lepr Other Mycobact Dis; 1974; 42(4):392-8. PubMed ID: 4142476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attempts at growth of M. leprae in mice and observations on a case of probable contamination with another acid-fast bacillus.
    Ogawa T
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):27-38. PubMed ID: 776864
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
    Fieldsteel AH; Levy L
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of 3,4-dihydroxyphenylalanine by connective tissue constituents. Identification of Mycobacterium leprae not related to phenolase activity.
    Kato L; Ishaque M; Adapoe C
    Int J Lepr Other Mycobact Dis; 1976; 44(4):435-42. PubMed ID: 828625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cultivation of leprosy bacilli in hyaluronic acid-based medium. 2. Progress and developing concept of the role of hyaluronic acid suggested by culture and armadillo infection studies.
    Skinsnes OK; Kuba BA; Chang PH; Kuwahara T
    Int J Lepr Other Mycobact Dis; 1978; 46(3-4):394-413. PubMed ID: 32143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid, B-glucuronidase, vitamin C and the immune defect in leprosy.
    Skinsnes AK; Matsuo E
    Int J Dermatol; 1976 May; 15(4):286-9. PubMed ID: 773848
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro cultivation of leprosy bacilli on hyaluronic acid based medium. 1. Preliminary report.
    Skinsnes OK; Matsuo E; Chang PH; Andersson B
    Int J Lepr Other Mycobact Dis; 1975; 43(3):193-203. PubMed ID: 767262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
    Gelber RH; Humphres RC; Fieldsteel AH
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.
    Guelpa-Lauras CC; Perani EG; Giroir AM; Grosset JH
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):70-7. PubMed ID: 3549940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
    Ebenezer GJ; Daniel S; Norman G; Daniel E; Job CK
    Indian J Lepr; 2004; 76(3):199-206. PubMed ID: 15835604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
    Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary dapsone-resistant leprosy in San Francisco.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
    Ji BH; Chen JK; Lu XZ; Wang SY; Ni GX; Hou YH; Zhou DH; Tang QK
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):563-77. PubMed ID: 3546547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse foot pad growth of M. leprae in relation to bacteriological index.
    Bhatia VN; Balakrishnan S; Venkataramaniah HN; Harikrishnan S
    Lepr India; 1983 Apr; 55(2):247-51. PubMed ID: 6355651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
    Dhople AM
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.